(Total Views: 66)
Posted On: 10/13/2023 1:30:48 PM
Post# of 27274

$NKTR News Article - Nektar Presents New Responder Data for Rezpegaldesleukin, a First-in-Class Selective Regulatory T-cell Therapy, in Late-Breaking News Oral Presentation at 2023 EADV Congress https://marketwirenews.com/news-releases/nekt...58477.html


My Twitter: WhyteStocks